These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232 [TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646 [TBL] [Abstract][Full Text] [Related]
5. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease. Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314 [TBL] [Abstract][Full Text] [Related]
6. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth. Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724 [TBL] [Abstract][Full Text] [Related]
7. Initiation and propagation of α-synuclein aggregation in the nervous system. Hijaz BA; Volpicelli-Daley LA Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659 [TBL] [Abstract][Full Text] [Related]
8. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283 [TBL] [Abstract][Full Text] [Related]
9. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]
10. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers. Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171 [TBL] [Abstract][Full Text] [Related]
11. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils. Ruggeri FS; Benedetti F; Knowles TPJ; Lashuel HA; Sekatskii S; Dietler G Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7230-7235. PubMed ID: 29941606 [TBL] [Abstract][Full Text] [Related]
12. A glimpse into the structural properties of α-synuclein oligomers. Santos J; Pallarès I; Ventura S Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360 [TBL] [Abstract][Full Text] [Related]
13. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
14. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein. Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568 [TBL] [Abstract][Full Text] [Related]
15. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons. Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724 [TBL] [Abstract][Full Text] [Related]
16. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
17. Nanoscopic insights into seeding mechanisms and toxicity of α-synuclein species in neurons. Pinotsi D; Michel CH; Buell AK; Laine RF; Mahou P; Dobson CM; Kaminski CF; Kaminski Schierle GS Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3815-9. PubMed ID: 26993805 [TBL] [Abstract][Full Text] [Related]
18. All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species. Franco A; Gracia P; Colom A; Camino JD; Fernández-Higuero JÁ; Orozco N; Dulebo A; Saiz L; Cremades N; Vilar JMG; Prado A; Muga A Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34462355 [TBL] [Abstract][Full Text] [Related]
19. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease. Zaidi FK; Deep S Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603 [TBL] [Abstract][Full Text] [Related]